E

Eloxx Pharmaceuticals Inc
D

ELOX

12.310
USD
-1.98
(-13.86%)
مغلق
حجم التداول
0
الربح لكل سهم
-8
العائد الربحي
-
P/E
-9
حجم السوق
42,301,025
المقالات
المزيد

العنوان: Eloxx Pharmaceuticals Inc

القطاع: Healthcare
الصناعة: Biotechnology
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.